US Patent No: 6,124,269

Number of patents in Portfolio can not be more than 2000

2-Halo-6-O-substituted ketolide derivatives

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Novel 2-halo-6-O-substituted ketolide derivatives and pharmaceutically acceptable salts and esters thereof having antibacterial activity having a formula ##STR1## compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention, and processes for their preparation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
ABBOTT LABORATORIESABBOTT PARK, IL1231

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Yan Grayslake, IL 279 2313
Chu, Daniel T Santa Clara, CA 56 737
Clark, Richard F Mundelein, IL 43 353
Or, Yat Sun Libertyville, IL 273 3458
Phan, Ly Tam Park City, IL 74 369
Platter, Jacob J Berkeley, CA 1 52

Cited Art Landscape

Patent Info (Count) # Cites Year
 
AVENTIS PHARMA S.A. (2)
* 5,444,051 Erythromycin compounds 73 1993
* 5,747,467 Erythromycins 44 1996
 
TAISHO PHARMACEUTICAL CO., LTD. (3)
* 4,990,602 Erythromycin A derivatives 75 1988
* 5,403,923 6-0-methylerythromycin A derivatives 37 1993
* 5,631,355 5-O-desosaminylerythronolide a derivatives 31 1994
 
ABBVIE INC. (1)
* 5,866,549 6-O-substituted ketolides having antibacterial activity 94 1997
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
PALUMED S.A. (1)
* 2007/0060,558 Hybrid molecules QA where Q is an aminoquinoline and A is an antibiotic residue, the synthesis and uses thereof as antibacterial agents 11 2006
 
Other [Check patent profile for assignment information] (1)
* 2004/0266,998 6,11-4-Carbon bridged ketolides 0 2004
 
ENANTA PHARMACEUTICALS (1)
6,720,308 Anhydrolide derivatives having antibacterial activity 2 2002
 
Enanra Pharmaceuticals, Inc. (1)
6,841,664 6,11-4-carbon bridged ketolides 2 2002
 
Enanta Pharmaceuticals, Inc. (36)
6,440,942 14-membered macrolides derived from leucomycins 7 2000
6,436,906 9-amino-14-membered macrolides derived from leucomycins 7 2001
6,753,318 6,11-4-carbon bridged erythromycin derivatives 3 2002
6,727,229 11,12-substituted lactone ketolide derivatives having antibacterial activity 0 2002
6,645,941 6,11-3C-bicyclic 9a-azalide derivatives 13 2003
6,878,691 6-11 bicyclic ketolide derivatives 27 2003
7,129,221 6,11-bicyclic erythromycin derivatives 9 2003
6,790,835 Bicyclic macrolide derivatives 0 2003
6,774,115 6-O-substituted bicyclic ketolides 0 2003
6,765,016 Bicyclic ketolide derivatives 1 2003
6,716,820 6-O-substituted bicyclic macrolides 0 2003
6,764,998 6,11-4C-bicyclic 9a-azalide derivatives 14 2003
7,064,110 6-11 bicycle ketolide derivatives 6 2003
7,022,679 Processes for the preparation of 6-11 bicyclic erythromycin derivatives 7 2004
* 2004/0171,818 Processes for the preparation of 6-11 bicyclic erythromycin derivatives 0 2004
7,910,558 Bridged macrocyclic compounds and processes for the preparation thereof 0 2004
* 2005/0009,761 Bridged macrocyclic compounds and processes for the preparation thereof 13 2004
7,049,417 6,11-4-Carbon bridged ketolides 3 2004
7,276,487 9a, 11-3C-bicyclic 9a-azalide derivatives 0 2004
7,414,030 6-11 Bicyclic erythromycin derivatives 4 2005
7,265,094 9N-substituted 6-11 bicyclic erythromycin derivatives 3 2005
* 2005/0171,033 9N-substituted 6-11 bicyclic erythromycin derivatives 0 2005
7,273,853 6-11 bicyclic ketolide derivatives 17 2005
* 2005/0159,370 English Title Not Available 0 2005
7,189,704 6-11 bicyclic ketolide derivatives 5 2005
7,135,573 Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine 7 2005
* 2009/0118,506 6,11-BRIDGED BIARYL MACROLIDES 6 2008
* 2009/0075,915 6,11-BICYCLOLIDES: BRIDGED BIARYL MACROLIDE DERIVATIVES 6 2008
8,273,720 6,11-bicyclolides: bridged biaryl macrolide derivatives 0 2009
8,354,383 6,11-bridged biaryl macrolides 0 2009
* 2009/0264,380 6,11-BRIDGED BIARYL MACROLIDES 4 2009
8,552,162 Processes for the preparation of 2 fluoro 6-11 bicyclic erythromycin derivatives 0 2009
8,383,785 Anti-bacterial activity of 9-hydroxy derivatives of 6,11-bicyclolides 0 2009
* 2009/0281,050 ANTI-BACTERIAL ACTIVITY OF 9-HYDROXY DERIVATIVES OF 6,11-BICYCLOLIDES 0 2009
* 2009/0281,293 PROCESSES FOR THE PREPARATION OF 2 FLUORO 6-11 BICYCLIC ERYTHROMYCIN DERIVATIVES 0 2009
9,242,974 Processes for the preparation of 2-fluoro 6-11 bicyclic erythromycin derivatives 0 2013
 
CHIRON CORPORATION (2)
7,163,924 Ketolide derivatives 8 2004
* 2005/0153,905 Novel ketolide derivatives 10 2004
 
Ortho-McNeil Pharmaceutical, Inc. (3)
6,458,771 Ketolide antibacterials 6 2000
6,399,582 Ketolide antibacterials 32 2000
6,590,083 Ketolide antibacterials 7 2000
 
ABBVIE INC. (3)
6,455,680 Methods utilizing aryl thioimines in synthesis of erythromycin derivatives 2 2000
7,071,314 Arylation method for the functionalization of O-allyl erythromycin derivatives 0 2002
* 6,998,390 Oxolide antibacterials 1 2003
 
PLIVA D.D. (2)
6,900,183 Macrolide antibiotics 1 2001
* 2004/0082,526 Macrolide antibiotics 0 2003
 
Kosan Biosciences, Inc. (12)
6,451,768 Macrolide antiinfective agents 5 2000
6,395,710 Macrolide antiinfective agents 20 2000
6,514,944 Macrolide antiinfective agents 6 2000
6,593,302 Macrolide antiinfective agents 5 2002
6,794,366 Macrolide antiinfective agents 2 2002
* 6,939,861 Amido macrolides 1 2003
* 2003/0199,458 Amido macrolides 0 2003
6,762,168 Macrolide antiinfective agents 4 2003
8,063,021 Ketolide anti-infective compounds 0 2004
* 2005/0272,672 Ketolide anti-infective compounds 0 2004
RE39836 Macrolide antinfective agents 1 2005
7,595,300 7-quinolyl ketolide antibacterial agents 0 2006
 
PFIZER PRODUCTS INC. (1)
6,809,080 Macrolide antibiotics 0 2001
 
AVENTIS PHARMA S.A. (2)
* 6,352,983 2-halogenated derivatives of 5-0 desosaminyl-erythronolide A, their preparation process and their antibiotic use 1 1999
* RE39743 2-halogenated derivatives of 5-0 desosaminyl-erythronolide a, their preparation process and their antibiotic use 0 2002
 
ABBOTT LABORATORIES (1)
* 2004/0014,690 Macrolides with activity against methicillin-resistant staphylococcus aureus 5 2003
 
Far East Medical, LLC (1)
* 2005/0125,885 Foldable toilet-sitting appliance 0 2004
 
CLEMSON UNIVERSITY (3)
7,071,288 Terpolymers from lactide 2 2004
* 2005/0004,338 Novel terpolymers from lactide 1 2004
7,754,826 Copolymers from lactide 1 2006
* Cited By Examiner